Abstract:BACKGROUND: Exposure to air pollution increases cardiovascular morbidity and mortality. Preventing chronic cardiovascular diseases caused by air pollution relies on detecting the early effects of pollutants on the risk of cardiovascular disease development, which is limited by the lack of sensitive biomarkers. We have previously identified promising biomarkers in experimental animals but comparable evidence in humans is lacking. METHODS: Air pollution is substantially worse in Beijing than in Los Angeles. We collected urine and blood samples from 26 nonsmoking, healthy adult residents of Los Angeles (mean age, 23.8 years; 14 women) before, during, and after spending 10 weeks in Beijing during the summers of 2014 and 2015. We assessed a panel of circulating biomarkers indicative of lipid peroxidation and inflammation. Personal exposure to polycyclic aromatic hydrocarbons (PAHs), a group of combustion-originated air pollutants, was assessed by urinary PAH metabolite levels. RESULTS: Urinary concentrations of 4 PAH metabolites were 176% (95% CI, 103% to 276%) to 800% (95% CI, 509% to 1780%) greater in Beijing than in Los Angeles. Concentrations of 6 lipid peroxidation biomarkers were also increased in Beijing, among which 5-, 12-, and 15-hydroxyeicosatetraenoic acid and 9- and 13-hydroxyoctadecadienoic acid levels reached statistical significance (false discovery rate <5%), but not 8-isoprostane (20.8%; 95% CI, -5.0% to 53.6%). The antioxidative activities of paraoxonase (-9.8%; 95% CI, -14.0% to -5.3%) and arylesterase (-14.5%; 95% CI, -22.3% to -5.8%) were lower and proinflammatory C-reactive protein (101%; 95% CI, 3.3% to 291%) and fibrinogen (48.3%; 95% CI, 4.9% to 110%) concentrations were higher in Beijing. Changes in all these biomarkers were reversed, at least partially, after study participants returned to Los Angeles. Changes in most outcomes were associated with urinary PAH metabolites (P<0.05). CONCLUSIONS: Traveling from a less-polluted to a more-polluted city induces systemic pro-oxidative and proinflammatory effects. Changes in the levels of 5-, 12-, and 15-hydroxyeicosatetraenoic acid and 9- and 13-hydroxyoctadecadienoic acid as well as paraoxonase and arylesterase activities in the blood, in association with exposures to PAH metabolites, might have important implications in preventive medicine as indicators of increased cardiovascular risk caused by air pollution exposure.

Metabolomic Changes after Subacute Exposure to Polycyclic Aromatic Hydrocarbons: A Natural Experiment among Healthy Travelers from Los Angeles to Beijing.

Urinary Metabolites of Polycyclic Aromatic Hydrocarbons and the Association with Lipid Peroxidation: A Biomarker-Based Study Between Los Angeles and Beijing.

Pro-Oxidative and Pro-Inflammatory Effects After Traveling from Los Angeles to Beijing: A Biomarker-Based Natural Experiment.

Human Metabolic Responses to Chronic Environmental Polycyclic Aromatic Hydrocarbon Exposure by A Metabolomic Approach

Passive Smoking Increases Exposure to Polycyclic Aromatic Hydrocarbons and Leads to Prolonged Lipid Oxidation: Lessons from a Natural Experiment in Travelers from Los Angeles to Beijing

Arachidonic acid metabolism and inflammatory biomarkers associated with exposure to polycyclic aromatic hydrocarbons

Environmental Exposure Induced Metabolic Profiling Alterations in a Migration Panel Between Los Angeles and Beijing

Metabolomic Alterations in Healthy Adults Traveling to Low-Pollution Areas: A Natural Experiment with Ozone Exposure

Urinary carboxylic acid metabolites as possible novel biomarkers of exposures to alkylated polycyclic aromatic hydrocarbons.

Abstract 4142331: Metabolomic Signature of Mitochondrial Dysfunction after Subacute Air Pollution Exposure: an Animal-to-Human Translational Study

Passive smoking and urinary oxidative biomarkers: A pilot study of healthy travelers from Los Angeles to Beijing

Triglyceride Profiles Are Associated with Subacute Exposure to Bisphenol a in Healthy Young Adults.

Dietary and Inhalation Exposure to Polycyclic Aromatic Hydrocarbons and Urinary Excretion of Monohydroxy Metabolites – A Controlled Case Study in Beijing, China

Human exposure to polycyclic aromatic hydrocarbons: Metabolomics perspective

Multiple categories of polycyclic aromatic hydrocarbons in atmospheric PM2.5 associated with changes in lipid profiles: A longitudinal study in Beijing

Effects of Environmental and Lifestyle Exposures on Urinary Levels of Polycyclic Aromatic Hydrocarbon Metabolites: A Cross-Sectional Study of Urban Adults in China

Changes in the Non-targeted Metabolomic Profile of Three-year-old Toddlers with Elevated Exposure to Polycyclic Aromatic Hydrocarbons

Rewiring the nexus between urban traffic pollution-derived polycyclic aromatic hydrocarbon exposure and DNA injury via urinary metabolomics

Association Between Urinary Polycyclic Aromatic Hydrocarbon Metabolites and Dyslipidemias in the Chinese General Population: A Cross-Sectional Study.

Exposure to polycyclic aromatic hydrocarbons (PAHs) in outdoor air and respiratory health, inflammation and oxidative stress biomarkers: A panel study in healthy young adults

Metabolomics perspectives into the co-exposure effect of polycyclic aromatic hydrocarbons and metals on renal function: A meet-in-the-middle approach